Devajit Mohajan and Haradhan Kumar Mohajan 2024. Alpha-Glucosidase Inhibitors (AGIs): A New Class of Oral Medication for Treatment of Type 2 Diabetes Patients. Journal of Innovations in Medical Research. 3, 4 (Nov. 2024), 1–6.